Additionally, we have also demonstrated that GPC3-redirected T cells (CAR-T) cells could eradicate GPC3-positive HCC xenografts [23], and we have launched a first-in-human study on GPC3-redirected CAR-T cells (NCT02395250). This evidence concerns the gene GPC3 and hepatocellular carcinoma.